Request for Covid-19 Impact Assessment of this Report
The United States Celiac Drugs market is expected at value of US$ million in 2021 and grow at approximately % CAGR during review period. China constitutes a % market for the global Celiac Drugs market, reaching US$ million by the year 2028. As for the Europe Celiac Drugs landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period. In APAC, the growth rates of other notable markets (Japan and South Korea) are projected to be at % and % respectively for the next 5-year period.
Global main Celiac Drugs players cover ADMA Biologics, Amgen, Anthera Pharmaceuticals, and Bayer, etc. In terms of revenue, the global largest two companies occupy a share nearly % in 2021.
This report presents a comprehensive overview, market shares, and growth opportunities of Celiac Drugs market by product type, application, key manufacturers and key regions and countries.
Segmentation by type: breakdown data from 2017 to 2022, in Section 2.3; and forecast to 2028 in section 12.6
First Line Of Treatment
Second Line Of Treatment
Segmentation by application: breakdown data from 2017 to 2022, in Section 2.4; and forecast to 2028 in section 12.7.
Men
Women
Children
This report also splits the market by region: Breakdown data in Chapter 4, 5, 6, 7 and 8.
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The report also presents the market competition landscape and a corresponding detailed analysis of the prominent manufacturers in this market, include
ADMA Biologics
Amgen
Anthera Pharmaceuticals
Bayer
Biogen
BioLineRx
Biotest
Bristol-Myers Squibb
Celgene
Celimmune
F Hoffmann-La Roche
ImmunogenX
Immunomedics
ImmusanT
Innovate Biopharmaceuticals
Johnson & Johnson
Kedrion Biopharma
LFB Group
Merck
Novartis
1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
2 Executive Summary
2.1 World Market Overview
2.1.1 Global Celiac Drugs Annual Sales 2017-2028
2.1.2 World Current & Future Analysis for Celiac Drugs by Geographic Region, 2017, 2022 & 2028
2.1.3 World Current & Future Analysis for Celiac Drugs by Country/Region, 2017, 2022 & 2028
2.2 Celiac Drugs Segment by Type
2.2.1 First Line Of Treatment
2.2.2 Second Line Of Treatment
2.3 Celiac Drugs Sales by Type
2.3.1 Global Celiac Drugs Sales Market Share by Type (2017-2022)
2.3.2 Global Celiac Drugs Revenue and Market Share by Type (2017-2022)
2.3.3 Global Celiac Drugs Sale Price by Type (2017-2022)
2.4 Celiac Drugs Segment by Application
2.4.1 Men
2.4.2 Women
2.4.3 Children
2.5 Celiac Drugs Sales by Application
2.5.1 Global Celiac Drugs Sale Market Share by Application (2017-2022)
2.5.2 Global Celiac Drugs Revenue and Market Share by Application (2017-2022)
2.5.3 Global Celiac Drugs Sale Price by Application (2017-2022)
3 Global Celiac Drugs by Company
3.1 Global Celiac Drugs Breakdown Data by Company
3.1.1 Global Celiac Drugs Annual Sales by Company (2020-2022)
3.1.2 Global Celiac Drugs Sales Market Share by Company (2020-2022)
3.2 Global Celiac Drugs Annual Revenue by Company (2020-2022)
3.2.1 Global Celiac Drugs Revenue by Company (2020-2022)
3.2.2 Global Celiac Drugs Revenue Market Share by Company (2020-2022)
3.3 Global Celiac Drugs Sale Price by Company
3.4 Key Manufacturers Celiac Drugs Producing Area Distribution, Sales Area, Product Type
3.4.1 Key Manufacturers Celiac Drugs Product Location Distribution
3.4.2 Players Celiac Drugs Products Offered
3.5 Market Concentration Rate Analysis
3.5.1 Competition Landscape Analysis
3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
3.6 New Products and Potential Entrants
3.7 Mergers & Acquisitions, Expansion
4 World Historic Review for Celiac Drugs by Geographic Region
4.1 World Historic Celiac Drugs Market Size by Geographic Region (2017-2022)
4.1.1 Global Celiac Drugs Annual Sales by Geographic Region (2017-2022)
4.1.2 Global Celiac Drugs Annual Revenue by Geographic Region
4.2 World Historic Celiac Drugs Market Size by Country/Region (2017-2022)
4.2.1 Global Celiac Drugs Annual Sales by Country/Region (2017-2022)
4.2.2 Global Celiac Drugs Annual Revenue by Country/Region
4.3 Americas Celiac Drugs Sales Growth
4.4 APAC Celiac Drugs Sales Growth
4.5 Europe Celiac Drugs Sales Growth
4.6 Middle East & Africa Celiac Drugs Sales Growth
5 Americas
5.1 Americas Celiac Drugs Sales by Country
5.1.1 Americas Celiac Drugs Sales by Country (2017-2022)
5.1.2 Americas Celiac Drugs Revenue by Country (2017-2022)
5.2 Americas Celiac Drugs Sales by Type
5.3 Americas Celiac Drugs Sales by Application
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil
6 APAC
6.1 APAC Celiac Drugs Sales by Region
6.1.1 APAC Celiac Drugs Sales by Region (2017-2022)
6.1.2 APAC Celiac Drugs Revenue by Region (2017-2022)
6.2 APAC Celiac Drugs Sales by Type
6.3 APAC Celiac Drugs Sales by Application
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia
6.10 China Taiwan
7 Europe
7.1 Europe Celiac Drugs by Country
7.1.1 Europe Celiac Drugs Sales by Country (2017-2022)
7.1.2 Europe Celiac Drugs Revenue by Country (2017-2022)
7.2 Europe Celiac Drugs Sales by Type
7.3 Europe Celiac Drugs Sales by Application
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia
8 Middle East & Africa
8.1 Middle East & Africa Celiac Drugs by Country
8.1.1 Middle East & Africa Celiac Drugs Sales by Country (2017-2022)
8.1.2 Middle East & Africa Celiac Drugs Revenue by Country (2017-2022)
8.2 Middle East & Africa Celiac Drugs Sales by Type
8.3 Middle East & Africa Celiac Drugs Sales by Application
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries
9 Market Drivers, Challenges and Trends
9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends
10 Manufacturing Cost Structure Analysis
10.1 Raw Material and Suppliers
10.2 Manufacturing Cost Structure Analysis of Celiac Drugs
10.3 Manufacturing Process Analysis of Celiac Drugs
10.4 Industry Chain Structure of Celiac Drugs
11 Marketing, Distributors and Customer
11.1 Sales Channel
11.1.1 Direct Channels
11.1.2 Indirect Channels
11.2 Celiac Drugs Distributors
11.3 Celiac Drugs Customer
12 World Forecast Review for Celiac Drugs by Geographic Region
12.1 Global Celiac Drugs Market Size Forecast by Region
12.1.1 Global Celiac Drugs Forecast by Region (2023-2028)
12.1.2 Global Celiac Drugs Annual Revenue Forecast by Region (2023-2028)
12.2 Americas Forecast by Country
12.3 APAC Forecast by Region
12.4 Europe Forecast by Country
12.5 Middle East & Africa Forecast by Country
12.6 Global Celiac Drugs Forecast by Type
12.7 Global Celiac Drugs Forecast by Application
13 Key Players Analysis
13.1 ADMA Biologics
13.1.1 ADMA Biologics Company Information
13.1.2 ADMA Biologics Celiac Drugs Product Offered
13.1.3 ADMA Biologics Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.1.4 ADMA Biologics Main Business Overview
13.1.5 ADMA Biologics Latest Developments
13.2 Amgen
13.2.1 Amgen Company Information
13.2.2 Amgen Celiac Drugs Product Offered
13.2.3 Amgen Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.2.4 Amgen Main Business Overview
13.2.5 Amgen Latest Developments
13.3 Anthera Pharmaceuticals
13.3.1 Anthera Pharmaceuticals Company Information
13.3.2 Anthera Pharmaceuticals Celiac Drugs Product Offered
13.3.3 Anthera Pharmaceuticals Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.3.4 Anthera Pharmaceuticals Main Business Overview
13.3.5 Anthera Pharmaceuticals Latest Developments
13.4 Bayer
13.4.1 Bayer Company Information
13.4.2 Bayer Celiac Drugs Product Offered
13.4.3 Bayer Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.4.4 Bayer Main Business Overview
13.4.5 Bayer Latest Developments
13.5 Biogen
13.5.1 Biogen Company Information
13.5.2 Biogen Celiac Drugs Product Offered
13.5.3 Biogen Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.5.4 Biogen Main Business Overview
13.5.5 Biogen Latest Developments
13.6 BioLineRx
13.6.1 BioLineRx Company Information
13.6.2 BioLineRx Celiac Drugs Product Offered
13.6.3 BioLineRx Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.6.4 BioLineRx Main Business Overview
13.6.5 BioLineRx Latest Developments
13.7 Biotest
13.7.1 Biotest Company Information
13.7.2 Biotest Celiac Drugs Product Offered
13.7.3 Biotest Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.7.4 Biotest Main Business Overview
13.7.5 Biotest Latest Developments
13.8 Bristol-Myers Squibb
13.8.1 Bristol-Myers Squibb Company Information
13.8.2 Bristol-Myers Squibb Celiac Drugs Product Offered
13.8.3 Bristol-Myers Squibb Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.8.4 Bristol-Myers Squibb Main Business Overview
13.8.5 Bristol-Myers Squibb Latest Developments
13.9 Celgene
13.9.1 Celgene Company Information
13.9.2 Celgene Celiac Drugs Product Offered
13.9.3 Celgene Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.9.4 Celgene Main Business Overview
13.9.5 Celgene Latest Developments
13.10 Celimmune
13.10.1 Celimmune Company Information
13.10.2 Celimmune Celiac Drugs Product Offered
13.10.3 Celimmune Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.10.4 Celimmune Main Business Overview
13.10.5 Celimmune Latest Developments
13.11 F Hoffmann-La Roche
13.11.1 F Hoffmann-La Roche Company Information
13.11.2 F Hoffmann-La Roche Celiac Drugs Product Offered
13.11.3 F Hoffmann-La Roche Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.11.4 F Hoffmann-La Roche Main Business Overview
13.11.5 F Hoffmann-La Roche Latest Developments
13.12 ImmunogenX
13.12.1 ImmunogenX Company Information
13.12.2 ImmunogenX Celiac Drugs Product Offered
13.12.3 ImmunogenX Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.12.4 ImmunogenX Main Business Overview
13.12.5 ImmunogenX Latest Developments
13.13 Immunomedics
13.13.1 Immunomedics Company Information
13.13.2 Immunomedics Celiac Drugs Product Offered
13.13.3 Immunomedics Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.13.4 Immunomedics Main Business Overview
13.13.5 Immunomedics Latest Developments
13.14 ImmusanT
13.14.1 ImmusanT Company Information
13.14.2 ImmusanT Celiac Drugs Product Offered
13.14.3 ImmusanT Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.14.4 ImmusanT Main Business Overview
13.14.5 ImmusanT Latest Developments
13.15 Innovate Biopharmaceuticals
13.15.1 Innovate Biopharmaceuticals Company Information
13.15.2 Innovate Biopharmaceuticals Celiac Drugs Product Offered
13.15.3 Innovate Biopharmaceuticals Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.15.4 Innovate Biopharmaceuticals Main Business Overview
13.15.5 Innovate Biopharmaceuticals Latest Developments
13.16 Johnson & Johnson
13.16.1 Johnson & Johnson Company Information
13.16.2 Johnson & Johnson Celiac Drugs Product Offered
13.16.3 Johnson & Johnson Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.16.4 Johnson & Johnson Main Business Overview
13.16.5 Johnson & Johnson Latest Developments
13.17 Kedrion Biopharma
13.17.1 Kedrion Biopharma Company Information
13.17.2 Kedrion Biopharma Celiac Drugs Product Offered
13.17.3 Kedrion Biopharma Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.17.4 Kedrion Biopharma Main Business Overview
13.17.5 Kedrion Biopharma Latest Developments
13.18 LFB Group
13.18.1 LFB Group Company Information
13.18.2 LFB Group Celiac Drugs Product Offered
13.18.3 LFB Group Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.18.4 LFB Group Main Business Overview
13.18.5 LFB Group Latest Developments
13.19 Merck
13.19.1 Merck Company Information
13.19.2 Merck Celiac Drugs Product Offered
13.19.3 Merck Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.19.4 Merck Main Business Overview
13.19.5 Merck Latest Developments
13.20 Novartis
13.20.1 Novartis Company Information
13.20.2 Novartis Celiac Drugs Product Offered
13.20.3 Novartis Celiac Drugs Sales, Revenue, Price and Gross Margin (2020-2022)
13.20.4 Novartis Main Business Overview
13.20.5 Novartis Latest Developments
14 Research Findings and Conclusion
Table 1. Celiac Drugs Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)
Table 2. Celiac Drugs Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)
Table 3. Major Players of First Line Of Treatment
Table 4. Major Players of Second Line Of Treatment
Table 5. Global Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 6. Global Celiac Drugs Sales Market Share by Type (2017-2022)
Table 7. Global Celiac Drugs Revenue by Type (2017-2022) & ($ million)
Table 8. Global Celiac Drugs Revenue Market Share by Type (2017-2022)
Table 9. Global Celiac Drugs Sale Price by Type (2017-2022) & (USD/MT)
Table 10. Global Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 11. Global Celiac Drugs Sales Market Share by Application (2017-2022)
Table 12. Global Celiac Drugs Revenue by Application (2017-2022)
Table 13. Global Celiac Drugs Revenue Market Share by Application (2017-2022)
Table 14. Global Celiac Drugs Sale Price by Application (2017-2022) & (USD/MT)
Table 15. Global Celiac Drugs Sales by Company (2020-2022) & (K MT)
Table 16. Global Celiac Drugs Sales Market Share by Company (2020-2022)
Table 17. Global Celiac Drugs Revenue by Company (2020-2022) ($ Millions)
Table 18. Global Celiac Drugs Revenue Market Share by Company (2020-2022)
Table 19. Global Celiac Drugs Sale Price by Company (2020-2022) & (USD/MT)
Table 20. Key Manufacturers Celiac Drugs Producing Area Distribution and Sales Area
Table 21. Players Celiac Drugs Products Offered
Table 22. Celiac Drugs Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)
Table 23. New Products and Potential Entrants
Table 24. Mergers & Acquisitions, Expansion
Table 25. Global Celiac Drugs Sales by Geographic Region (2017-2022) & (K MT)
Table 26. Global Celiac Drugs Sales Market Share Geographic Region (2017-2022)
Table 27. Global Celiac Drugs Revenue by Geographic Region (2017-2022) & ($ millions)
Table 28. Global Celiac Drugs Revenue Market Share by Geographic Region (2017-2022)
Table 29. Global Celiac Drugs Sales by Country/Region (2017-2022) & (K MT)
Table 30. Global Celiac Drugs Sales Market Share by Country/Region (2017-2022)
Table 31. Global Celiac Drugs Revenue by Country/Region (2017-2022) & ($ millions)
Table 32. Global Celiac Drugs Revenue Market Share by Country/Region (2017-2022)
Table 33. Americas Celiac Drugs Sales by Country (2017-2022) & (K MT)
Table 34. Americas Celiac Drugs Sales Market Share by Country (2017-2022)
Table 35. Americas Celiac Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 36. Americas Celiac Drugs Revenue Market Share by Country (2017-2022)
Table 37. Americas Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 38. Americas Celiac Drugs Sales Market Share by Type (2017-2022)
Table 39. Americas Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 40. Americas Celiac Drugs Sales Market Share by Application (2017-2022)
Table 41. APAC Celiac Drugs Sales by Region (2017-2022) & (K MT)
Table 42. APAC Celiac Drugs Sales Market Share by Region (2017-2022)
Table 43. APAC Celiac Drugs Revenue by Region (2017-2022) & ($ Millions)
Table 44. APAC Celiac Drugs Revenue Market Share by Region (2017-2022)
Table 45. APAC Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 46. APAC Celiac Drugs Sales Market Share by Type (2017-2022)
Table 47. APAC Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 48. APAC Celiac Drugs Sales Market Share by Application (2017-2022)
Table 49. Europe Celiac Drugs Sales by Country (2017-2022) & (K MT)
Table 50. Europe Celiac Drugs Sales Market Share by Country (2017-2022)
Table 51. Europe Celiac Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 52. Europe Celiac Drugs Revenue Market Share by Country (2017-2022)
Table 53. Europe Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 54. Europe Celiac Drugs Sales Market Share by Type (2017-2022)
Table 55. Europe Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 56. Europe Celiac Drugs Sales Market Share by Application (2017-2022)
Table 57. Middle East & Africa Celiac Drugs Sales by Country (2017-2022) & (K MT)
Table 58. Middle East & Africa Celiac Drugs Sales Market Share by Country (2017-2022)
Table 59. Middle East & Africa Celiac Drugs Revenue by Country (2017-2022) & ($ Millions)
Table 60. Middle East & Africa Celiac Drugs Revenue Market Share by Country (2017-2022)
Table 61. Middle East & Africa Celiac Drugs Sales by Type (2017-2022) & (K MT)
Table 62. Middle East & Africa Celiac Drugs Sales Market Share by Type (2017-2022)
Table 63. Middle East & Africa Celiac Drugs Sales by Application (2017-2022) & (K MT)
Table 64. Middle East & Africa Celiac Drugs Sales Market Share by Application (2017-2022)
Table 65. Key Market Drivers & Growth Opportunities of Celiac Drugs
Table 66. Key Market Challenges & Risks of Celiac Drugs
Table 67. Key Industry Trends of Celiac Drugs
Table 68. Celiac Drugs Raw Material
Table 69. Key Suppliers of Raw Materials
Table 70. Celiac Drugs Distributors List
Table 71. Celiac Drugs Customer List
Table 72. Global Celiac Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 73. Global Celiac Drugs Sales Market Forecast by Region
Table 74. Global Celiac Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 75. Global Celiac Drugs Revenue Market Share Forecast by Region (2023-2028)
Table 76. Americas Celiac Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 77. Americas Celiac Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 78. APAC Celiac Drugs Sales Forecast by Region (2023-2028) & (K MT)
Table 79. APAC Celiac Drugs Revenue Forecast by Region (2023-2028) & ($ millions)
Table 80. Europe Celiac Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 81. Europe Celiac Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 82. Middle East & Africa Celiac Drugs Sales Forecast by Country (2023-2028) & (K MT)
Table 83. Middle East & Africa Celiac Drugs Revenue Forecast by Country (2023-2028) & ($ millions)
Table 84. Global Celiac Drugs Sales Forecast by Type (2023-2028) & (K MT)
Table 85. Global Celiac Drugs Sales Market Share Forecast by Type (2023-2028)
Table 86. Global Celiac Drugs Revenue Forecast by Type (2023-2028) & ($ Millions)
Table 87. Global Celiac Drugs Revenue Market Share Forecast by Type (2023-2028)
Table 88. Global Celiac Drugs Sales Forecast by Application (2023-2028) & (K MT)
Table 89. Global Celiac Drugs Sales Market Share Forecast by Application (2023-2028)
Table 90. Global Celiac Drugs Revenue Forecast by Application (2023-2028) & ($ Millions)
Table 91. Global Celiac Drugs Revenue Market Share Forecast by Application (2023-2028)
Table 92. ADMA Biologics Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 93. ADMA Biologics Celiac Drugs Product Offered
Table 94. ADMA Biologics Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 95. ADMA Biologics Main Business
Table 96. ADMA Biologics Latest Developments
Table 97. Amgen Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 98. Amgen Celiac Drugs Product Offered
Table 99. Amgen Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 100. Amgen Main Business
Table 101. Amgen Latest Developments
Table 102. Anthera Pharmaceuticals Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 103. Anthera Pharmaceuticals Celiac Drugs Product Offered
Table 104. Anthera Pharmaceuticals Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 105. Anthera Pharmaceuticals Main Business
Table 106. Anthera Pharmaceuticals Latest Developments
Table 107. Bayer Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 108. Bayer Celiac Drugs Product Offered
Table 109. Bayer Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 110. Bayer Main Business
Table 111. Bayer Latest Developments
Table 112. Biogen Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 113. Biogen Celiac Drugs Product Offered
Table 114. Biogen Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 115. Biogen Main Business
Table 116. Biogen Latest Developments
Table 117. BioLineRx Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 118. BioLineRx Celiac Drugs Product Offered
Table 119. BioLineRx Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 120. BioLineRx Main Business
Table 121. BioLineRx Latest Developments
Table 122. Biotest Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 123. Biotest Celiac Drugs Product Offered
Table 124. Biotest Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 125. Biotest Main Business
Table 126. Biotest Latest Developments
Table 127. Bristol-Myers Squibb Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 128. Bristol-Myers Squibb Celiac Drugs Product Offered
Table 129. Bristol-Myers Squibb Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 130. Bristol-Myers Squibb Main Business
Table 131. Bristol-Myers Squibb Latest Developments
Table 132. Celgene Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 133. Celgene Celiac Drugs Product Offered
Table 134. Celgene Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 135. Celgene Main Business
Table 136. Celgene Latest Developments
Table 137. Celimmune Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 138. Celimmune Celiac Drugs Product Offered
Table 139. Celimmune Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 140. Celimmune Main Business
Table 141. Celimmune Latest Developments
Table 142. F Hoffmann-La Roche Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 143. F Hoffmann-La Roche Celiac Drugs Product Offered
Table 144. F Hoffmann-La Roche Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 145. F Hoffmann-La Roche Main Business
Table 146. F Hoffmann-La Roche Latest Developments
Table 147. ImmunogenX Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 148. ImmunogenX Celiac Drugs Product Offered
Table 149. ImmunogenX Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 150. ImmunogenX Main Business
Table 151. ImmunogenX Latest Developments
Table 152. Immunomedics Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 153. Immunomedics Celiac Drugs Product Offered
Table 154. Immunomedics Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 155. Immunomedics Main Business
Table 156. Immunomedics Latest Developments
Table 157. ImmusanT Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 158. ImmusanT Celiac Drugs Product Offered
Table 159. ImmusanT Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 160. ImmusanT Main Business
Table 161. ImmusanT Latest Developments
Table 162. Innovate Biopharmaceuticals Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 163. Innovate Biopharmaceuticals Celiac Drugs Product Offered
Table 164. Innovate Biopharmaceuticals Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 165. Innovate Biopharmaceuticals Main Business
Table 166. Innovate Biopharmaceuticals Latest Developments
Table 167. Johnson & Johnson Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 168. Johnson & Johnson Celiac Drugs Product Offered
Table 169. Johnson & Johnson Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 170. Johnson & Johnson Main Business
Table 171. Johnson & Johnson Latest Developments
Table 172. Kedrion Biopharma Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 173. Kedrion Biopharma Celiac Drugs Product Offered
Table 174. Kedrion Biopharma Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 175. Kedrion Biopharma Main Business
Table 176. Kedrion Biopharma Latest Developments
Table 177. LFB Group Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 178. LFB Group Celiac Drugs Product Offered
Table 179. LFB Group Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 180. LFB Group Main Business
Table 181. LFB Group Latest Developments
Table 182. Merck Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 183. Merck Celiac Drugs Product Offered
Table 184. Merck Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 185. Merck Main Business
Table 186. Merck Latest Developments
Table 187. Novartis Basic Information, Celiac Drugs Manufacturing Base, Sales Area and Its Competitors
Table 188. Novartis Celiac Drugs Product Offered
Table 189. Novartis Celiac Drugs Sales (K MT), Revenue ($ Million), Price (USD/MT) and Gross Margin (2020-2022)
Table 190. Novartis Main Business
Table 191. Novartis Latest Developments
List of Figures
Figure 1. Picture of Celiac Drugs
Figure 2. Celiac Drugs Report Years Considered
Figure 3. Research Objectives
Figure 4. Research Methodology
Figure 5. Research Process and Data Source
Figure 6. Global Celiac Drugs Sales Growth Rate 2017-2028 (K MT)
Figure 7. Global Celiac Drugs Revenue Growth Rate 2017-2028 ($ Millions)
Figure 8. Celiac Drugs Sales by Region (2021 & 2028) & ($ millions)
Figure 9. Product Picture of First Line Of Treatment
Figure 10. Product Picture of Second Line Of Treatment
Figure 11. Global Celiac Drugs Sales Market Share by Type in 2021
Figure 12. Global Celiac Drugs Revenue Market Share by Type (2017-2022)
Figure 13. Celiac Drugs Consumed in Men
Figure 14. Global Celiac Drugs Market: Men (2017-2022) & (K MT)
Figure 15. Celiac Drugs Consumed in Women
Figure 16. Global Celiac Drugs Market: Women (2017-2022) & (K MT)
Figure 17. Celiac Drugs Consumed in Children
Figure 18. Global Celiac Drugs Market: Children (2017-2022) & (K MT)
Figure 19. Global Celiac Drugs Sales Market Share by Application (2017-2022)
Figure 20. Global Celiac Drugs Revenue Market Share by Application in 2021
Figure 21. Celiac Drugs Revenue Market by Company in 2021 ($ Million)
Figure 22. Global Celiac Drugs Revenue Market Share by Company in 2021
Figure 23. Global Celiac Drugs Sales Market Share by Geographic Region (2017-2022)
Figure 24. Global Celiac Drugs Revenue Market Share by Geographic Region in 2021
Figure 25. Global Celiac Drugs Sales Market Share by Region (2017-2022)
Figure 26. Global Celiac Drugs Revenue Market Share by Country/Region in 2021
Figure 27. Americas Celiac Drugs Sales 2017-2022 (K MT)
Figure 28. Americas Celiac Drugs Revenue 2017-2022 ($ Millions)
Figure 29. APAC Celiac Drugs Sales 2017-2022 (K MT)
Figure 30. APAC Celiac Drugs Revenue 2017-2022 ($ Millions)
Figure 31. Europe Celiac Drugs Sales 2017-2022 (K MT)
Figure 32. Europe Celiac Drugs Revenue 2017-2022 ($ Millions)
Figure 33. Middle East & Africa Celiac Drugs Sales 2017-2022 (K MT)
Figure 34. Middle East & Africa Celiac Drugs Revenue 2017-2022 ($ Millions)
Figure 35. Americas Celiac Drugs Sales Market Share by Country in 2021
Figure 36. Americas Celiac Drugs Revenue Market Share by Country in 2021
Figure 37. United States Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 38. Canada Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 39. Mexico Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 40. Brazil Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 41. APAC Celiac Drugs Sales Market Share by Region in 2021
Figure 42. APAC Celiac Drugs Revenue Market Share by Regions in 2021
Figure 43. China Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 44. Japan Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 45. South Korea Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 46. Southeast Asia Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 47. India Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 48. Australia Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 49. Europe Celiac Drugs Sales Market Share by Country in 2021
Figure 50. Europe Celiac Drugs Revenue Market Share by Country in 2021
Figure 51. Germany Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 52. France Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 53. UK Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 54. Italy Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 55. Russia Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 56. Middle East & Africa Celiac Drugs Sales Market Share by Country in 2021
Figure 57. Middle East & Africa Celiac Drugs Revenue Market Share by Country in 2021
Figure 58. Egypt Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 59. South Africa Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 60. Israel Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 61. Turkey Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 62. GCC Country Celiac Drugs Revenue Growth 2017-2022 ($ Millions)
Figure 63. Manufacturing Cost Structure Analysis of Celiac Drugs in 2021
Figure 64. Manufacturing Process Analysis of Celiac Drugs
Figure 65. Industry Chain Structure of Celiac Drugs
Figure 66. Channels of Distribution
Figure 67. Distributors Profiles
The United States pneumococcal & meningococcal vaccines market is set to surpass US$ 7.5 Million by the year end of 2025. “United States Pneumococcal & Meningococcal Vaccines Market by Company Profile, Deals Type, Brand Analysis, Share, Key Trends & Opportunities to 2025” presents an in–depth assessment of the United States pneumococcal & meningococcal vaccines market dynamics, opportunitie...
The global human immunodeficiency virus (HIV) drugs market size is expected to surpass US$ 30 billion by 2025. “Global Human Immunodeficiency Virus (HIV) Drugs Market 2019 – 2025: Top 22 Drugs Analysis, Key Trends, Players and Forecasts” presents an in-depth assessment of the global human immunodeficiency virus (HIV) drugs market dynamics, opportunities, future roadmap, competitive landscap...
The global 50 blockbuster drugs market size is estimated to reach a value of US$ 292 billion by 2025. ‘’Global Blockbuster Drugs Market 2015 - 2025: Top 50 Drugs Analysis, Deal Trends, Players and Forecasts” presents an in-depth assessment of the global blockbuster drugs market dynamics, opportunities, future roadmap, competitive landscape and discusses major trends. The report offers the m...